Structure

InChI Key ZYGHJZDHTFUPRJ-UHFFFAOYSA-N
Smiles O=c1ccc2ccccc2o1
InChI
InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H

Physicochemical Descriptors

Property Name Value
Molecular Formula C9H6O2
Molecular Weight 146.14
AlogP 1.79
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 0.0
Polar Surface Area 30.21
Molecular species None
Aromatic Rings 2.0
Heavy Atoms 11.0
Assay Description Organism Bioactivity Reference
Compound was evaluated for percent inhibition of carrageenan induced rat paw edema at 0.005 mmol/kg Rattus norvegicus 30.2 %
Compound was evaluated for in vitro inhibition of chymotrypsinogen acting as esterase at 0.1 mM concentration None 28.5 %
Compound was evaluated for in vitro inhibition of chymotrypsinogen acting as esterase at 1 mM concentration None 63.9 %
Compound was evaluated for in vitro inhibition of chymotrypsinogen induced proteolysis at 1 mM concentration None 89.3 %
Compound was evaluated for in vitro inhibition of soybean lipoxygenase at 1 mM concentration None 15.1 %
In vitro inhibition of sirtuin 2 was evaluated using yeast whole cell lysates at 75 uM None 0.74 uM
Compound was evaluated for in vitro inhibition of trypsin acting as esterase at 0.1 mM concentration None 5.0 %
Compound was evaluated for in vitro inhibition of trypsin acting as esterase at 1 mM concentration None 98.0 %
Compound was evaluated for in vitro inhibition of trypsin induced proteolysis at 0.1 mM concentration None 12.7 %
Compound was evaluated for in vitro inhibition of trypsin induced proteolysis at 1 mM concentration None 95.9 %
Inhibitory concentration against soybean lipoxygenase upon incubation with sodium linoleate (0.1 mM) at RT Glycine max 15.1 %
Percent inhibition of carrageenan 2% (0.1 mL intradermal) induced paw edema at the i.p. dose of 0.01 m mol/kg in fisher 344 rats; n=5 Rattus norvegicus 30.2 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 22.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 0.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 0.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 36.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 28.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 5.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 53.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 16.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 10.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 600 ug/plate after 72 hrs Salmonella enterica subsp. enterica serovar Typhimurium 73.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 300 ug/plate after 72 hrs Salmonella enterica subsp. enterica serovar Typhimurium 17.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 150 ug/plate after 72 hrs Salmonella enterica subsp. enterica serovar Typhimurium 24.0 %
Inhibition of COX2 at 100 uM by scintillation proximity assay None 30.0 %
Pesticidal activity against Dermatophagoides pteronyssinus after 24 hrs Dermatophagoides pteronyssinus 0.032 g/m2
Inhibition of soybean lipoxygenase at 100 uM by UV absorbance based assay Glycine max 15.0 %
Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw edema at 0.01 mmol/kg, ip after 3.5 hrs Rattus norvegicus 30.0 %
Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration assay Homo sapiens 48.0 nM
Inhibition of human recombinant CA9 catalytic domain by stopped-flow CO2 hydration method Homo sapiens 100.0 nM
Inhibition of human recombinant CA12 catalytic domain by stopped-flow CO2 hydration method Homo sapiens 100.0 nM
Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/cytochalasin B-induced superoxide anion production at 10 ug/mL after 5 mins by spectrophotometer analysis Homo sapiens 8.5 %
Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/cytochalasin B-induced elastase release using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as elastase substrate at 10 ug/mL after 5 mins Homo sapiens 23.8 %
Antioxidant activity assessed as hydroxyl radical scavenging activity at 100 uM after 30 mins None 78.0 %
Inhibition of soybean lipoxygenase assessed as conversion of sodium linoleate to 13-hydroperoxylinoleic acid at 100 uM Glycine max 15.0 %
Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate at 500 uM after 60 mins by fluorescence quenching assay Homo sapiens 8.1 %
Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting Homo sapiens 7.6 %
Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 38.2 %
Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 9.3 %
Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 116.63 %
Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 99.05 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 2.66 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 23.55 % SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 24.36 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.02 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.02 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.02 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.02 %
Inhibition of human CYP2A6 at 10 uM Homo sapiens 98.19 %

Cross References

Resources Reference
ChEBI 28794
ChEMBL CHEMBL6466
DrugBank DB04665
DrugCentral 738
FDA SRS A4VZ22K1WT
Human Metabolome Database HMDB0001218
KEGG C05851
PDB COU
PubChem 323
SureChEMBL SCHEMBL6252
ZINC ZINC000000074709